6+Years of continuous engagement | ~40%Reduction in report turnaround time | 2→5+Service streams grew from the original mandate |
Context
The IP Strategy team of a global pharmaceutical company faced a persistent intelligence gap. With a lean internal team and a rapidly evolving technology landscape spanning device innovation and digital health, they needed a reliable, expert partner to deliver ongoing visibility into what competitors were doing — not just in filings, but in the strategic direction of their portfolios.
They engaged Evalueserve to provide structured, continuous technology monitoring across two parallel workstreams: device-segment innovation and digital health capabilities. The mandate was clear — track competitive activity, surface meaningful signals, and translate patent data into strategic insight for both the IP and R&D functions.
The Challenge
Patent intelligence at this scale is not a search problem — it is an analysis problem. The client needed to understand not just what competitors were filing, but what those filings revealed about technological evolution, unmet needs, and strategic white space.
Specific challenges included:
- Tracking a defined set of competitors across two distinct technology domains simultaneously
- Translating dense patent language into accessible, decision-ready intelligence for non-patent audiences within R&D
- Sustaining analytical quality and consistency across quarterly reporting cycles over multiple years
- Expanding the intelligence program as the client’s own digital strategy matured and new questions emerged
Our Approach
Continuous Monitoring as a Foundation
Evalueserve designed a dual-track monitoring program structured around the client’s internal technology taxonomy — a digital value chain spanning drug discovery through post-market activities. Monthly patent watch reports captured emerging filings within a defined set of competitors. At the same time, a quarterly newsletter synthesized the most strategically significant developments in a format designed for circulation among internal teams.
The quarterly newsletter became a shared intelligence layer for both IP and R&D — translating patent signals into language that informed product and portfolio decisions. |
Deep-Dive Competitive Intelligence
As the client’s understanding of the competitive landscape deepened, so did the scope of engagement. Ad hoc projects evolved from the monitoring foundation, including:
- Focused CI profiles on individual competitors active in digital health, assessing their technology positioning relative to the broader field
- Landscape analyses of how digital health technologies were evolving across specific segments of the value chain
- A structured benchmarking exercise in which 10–15 pharmaceutical peers were assessed side-by-side across digital capability areas — evaluating maturity, focus areas, and differentiation
Each project was grounded in patent analysis but extended into publicly available market signals, giving the client a fuller picture of competitive intent without requiring separate market research engagements.
AI-Augmented Workflow
To sustain analytical quality at scale and reduce turnaround time without compromising depth, Evalueserve introduced an AI-assisted analysis layer using its internal data intelligence platform. The workflow shift was significant:
Previously, analysts read each patent in full to identify and articulate the underlying technology need. The new workflow uses iteratively refined prompts to generate structured technology characterizations for each patent, presenting analysts with a set of candidate descriptors to verify and refine — rather than construct from scratch.
The result was a material reduction in report turnaround time (from approximately 10 days to 6 days) while preserving the expert judgment that makes the analysis actionable rather than merely informational.
The Questions We Were Built to Answer
Across six years, the intelligence program evolved in direct response to the client’s strategic priorities. The questions below reflect the progression from foundational monitoring to executive-level intelligence.
|
Strategic Question
|
How We Responded
|
|---|---|
|
What are our key competitors doing in device and digital health — and how fast are they moving?
|
Monthly patent watch reports tracking filing activity across a defined competitor set, with quarterly synthesis highlighting significant shifts
|
|
What is a specific competitor's technology posture in digital health, and how do they compare to the field?
|
Focused competitive intelligence profiles assessing individual competitors' patent portfolios, technology focus areas, and relative positioning
|
|
How is the digital health technology landscape evolving across our value chain?
|
Sector-level landscape analyses mapped to the client's internal digital value chain, from drug discovery through post-market
|
|
Where do we stand relative to our pharmaceutical peers in digital capabilities — and where are our differentiators limited?
|
A structured benchmarking study across 10–15 peer companies, assessing digital maturity, strategic focus, and competitive differentiation
|
|
What should we invest in — and what should we deprioritize — given where competitors are heading?
|
Longitudinal intelligence is synthesized into a strategic context and shared directly with R&D and IP Strategy leadership.
|
Outcomes
What began as a monitoring program became a strategic intelligence asset. The continuous nature of the engagement means the client now has six years of structured, comparable data on how competitors have evolved — a longitudinal view that no single landscape study could replicate.
Key outcomes include:
- Consistent, quarterly visibility into competitor patent activity, enabling proactive portfolio positioning and freedom-to-operate awareness for the IP Strategy team
- Translated technology intelligence informing decisions about investment priorities and development direction, the R&D team
- A benchmarked view of how the company stands relative to peers across the full digital value chain, supporting the executive-level strategic planning of the Digital Strategy team
Expanding Scope as a Signal of Trust
The evolution of the engagement tells its own story. From two monitoring streams, the program grew to include targeted CI projects, full landscape studies, and a company-wide digital benchmarking initiative — all stemming from the original mandate.
The client’s willingness to bring increasingly strategic questions to this engagement reflects a partnership model built on analytical rigor and consistent delivery — not just transactional output. |
Why Evalueserve
The value in this engagement was not simply in executing searches or producing reports. It was in the ability to:
- Maintain analytical continuity and institutional knowledge over a multi-year program
- Translate highly technical patent content into a strategic narrative for non-specialist audiences
- Expand in scope and depth as the client’s intelligence needs evolved
- Integrate AI tooling into an analyst-led workflow in a way that improves efficiency without eroding quality
For companies managing lean IP functions alongside growing strategic complexity, this kind of embedded intelligence partnership — one that scales with the organization — represents a meaningfully different model than project-by-project research procurement.
Looking to transform monitoring into strategic decision support? Explore how Evalueserve combines continuous technology intelligence, competitive benchmarking, AI-assisted workflows, and expert analysis to help IP and R&D leaders make faster, more confident innovation decisions. Explore our Innovation Intelligence Solutions or discover our broader IP & R&D Solutions.
